These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7507662)

  • 21. Three-dimensional structure of the immunophilin-like domain of FKBP59 in solution.
    Craescu CT; Rouvière N; Popescu A; Cerpolini E; Lebeau MC; Baulieu EE; Mispelter J
    Biochemistry; 1996 Aug; 35(34):11045-52. PubMed ID: 8780506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A putative sirolimus (rapamycin) effector protein.
    Chen Y; Chen H; Rhoad AE; Warner L; Caggiano TJ; Failli A; Zhang H; Hsiao CL; Nakanishi K; Molnar-Kimber KL
    Biochem Biophys Res Commun; 1994 Aug; 203(1):1-7. PubMed ID: 7521160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells.
    Fruman DA; Wood MA; Gjertson CK; Katz HR; Burakoff SJ; Bierer BE
    Eur J Immunol; 1995 Feb; 25(2):563-71. PubMed ID: 7533090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PPIase catalysis by human FK506-binding protein proceeds through a conformational twist mechanism.
    Park ST; Aldape RA; Futer O; DeCenzo MT; Livingston DJ
    J Biol Chem; 1992 Feb; 267(5):3316-24. PubMed ID: 1371117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of a plant FKBP12 that does not mediate action of FK506 and rapamycin.
    Xu Q; Liang S; Kudla J; Luan S
    Plant J; 1998 Aug; 15(4):511-9. PubMed ID: 9753776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapamycin-FKBP12 blocks proliferation, induces differentiation, and inhibits cdc2 kinase activity in a myogenic cell line.
    Jayaraman T; Marks AR
    J Biol Chem; 1993 Dec; 268(34):25385-8. PubMed ID: 7503980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP.
    Choi J; Chen J; Schreiber SL; Clardy J
    Science; 1996 Jul; 273(5272):239-42. PubMed ID: 8662507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mammalian protein targeted by G1-arresting rapamycin-receptor complex.
    Brown EJ; Albers MW; Shin TB; Ichikawa K; Keith CT; Lane WS; Schreiber SL
    Nature; 1994 Jun; 369(6483):756-8. PubMed ID: 8008069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probing hydration contributions to the thermodynamics of ligand binding by proteins. Enthalpy and heat capacity changes of tacrolimus and rapamycin binding to FK506 binding protein in D2O and H2O.
    Connelly PR; Thomson JA; Fitzgibbon MJ; Bruzzese FJ
    Biochemistry; 1993 Jun; 32(21):5583-90. PubMed ID: 7684925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex.
    Kissinger CR; Parge HE; Knighton DR; Lewis CT; Pelletier LA; Tempczyk A; Kalish VJ; Tucker KD; Showalter RE; Moomaw EW
    Nature; 1995 Dec; 378(6557):641-4. PubMed ID: 8524402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational polymorphism in peptidic and nonpeptidic drug molecules.
    Taylor P; Mikol V; Kallen J; Burkhard P; Walkinshaw MD
    Biopolymers; 1996; 40(5):585-92. PubMed ID: 9101762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characterization of a FKBP-type immunophilin from higher plants.
    Luan S; Kudla J; Gruissem W; Schreiber SL
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6964-9. PubMed ID: 8692927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological identification of a 50 kDa Mr FK506-binding immunophilin as a component of the non-DNA binding, hsp90 and hsp70 containing, heterooligomeric form of the chick oviduct progesterone receptor.
    Renoir JM; Pahl A; Keller U; Baulieu EE
    C R Acad Sci III; 1993 Dec; 316(12):1410-6. PubMed ID: 7522118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FKBP12 physically and functionally interacts with aspartokinase in Saccharomyces cerevisiae.
    Alarcón CM; Heitman J
    Mol Cell Biol; 1997 Oct; 17(10):5968-75. PubMed ID: 9315655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppressor binding to the immunophilin FKBP59 affects the local structural dynamics of a surface beta-strand: time-resolved fluorescence study.
    Rouviere N; Vincent M; Craescu CT; Gallay J
    Biochemistry; 1997 Jun; 36(24):7339-52. PubMed ID: 9200682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enthalpy of hydrogen bond formation in a protein-ligand binding reaction.
    Connelly PR; Aldape RA; Bruzzese FJ; Chambers SP; Fitzgibbon MJ; Fleming MA; Itoh S; Livingston DJ; Navia MA; Thomson JA
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1964-8. PubMed ID: 7510408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-sensitivity sequencing of large proteins: partial structure of the rapamycin-FKBP12 target.
    Erdjument-Bromage H; Lui M; Sabatini DM; Snyder SH; Tempst P
    Protein Sci; 1994 Dec; 3(12):2435-46. PubMed ID: 7756997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity studies of rapamycin analogs: evidence that the C-7 methoxy group is part of the effector domain and positioned at the FKBP12-FRAP interface.
    Luengo JI; Yamashita DS; Dunnington D; Beck AK; Rozamus LW; Yen HK; Bossard MJ; Levy MA; Hand A; Newman-Tarr T
    Chem Biol; 1995 Jul; 2(7):471-81. PubMed ID: 9383449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consensus preferred hydration sites in six FKBP12-drug complexes.
    Faerman CH; Karplus PA
    Proteins; 1995 Sep; 23(1):1-11. PubMed ID: 8539241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functions of FKBP12 and mitochondrial cyclophilin active site residues in vitro and in vivo in Saccharomyces cerevisiae.
    Dolinski K; Scholz C; Muir RS; Rospert S; Schmid FX; Cardenas ME; Heitman J
    Mol Biol Cell; 1997 Nov; 8(11):2267-80. PubMed ID: 9362068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.